l-arginine improves dystrophic phenotype in mdx mice
A possible treatment for Duchenne muscular dystrophies would be to compensate for dystrophin loss by increasing the expression of utrophin, another cytoskeletal protein of the muscle membrane. We previously found that l-arginine, the substrate for nitric oxide synthase, significantly increased utrop...
Main Authors: | Vincent Voisin, Catherine Sébrié, Stéfan Matecki, Hua Yu, Brigitte Gillet, Michèle Ramonatxo, Maurice Israël, Sabine De la Porte |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-10-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996105000677 |
Similar Items
-
Arginine butyrate per os protects mdx mice against cardiomyopathy, kyphosis and changes in axonal excitability
by: Sara Vianello, et al.
Published: (2014-11-01) -
Early administration of L‐arginine in mdx neonatal mice delays the onset of muscular dystrophy in tibialis anterior (TA) muscle
by: Roy W. R. Dudley, et al.
Published: (2021-08-01) -
PGC‐1α overexpression increases transcription factor EB nuclear localization and lysosome abundance in dystrophin‐deficient skeletal muscle
by: Hannah R. Spaulding, et al.
Published: (2020-02-01) -
MALDI reveals membrane lipid profile reversion in MDX mice
by: Farida Benabdellah, et al.
Published: (2009-11-01) -
High Throughput Screening in Duchenne Muscular Dystrophy: From Drug Discovery to Functional Genomics
by: Thomas J.J. Gintjee, et al.
Published: (2014-11-01)